Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vopr Onkol ; 59(5): 620-2, 2013.
Artigo em Russo | MEDLINE | ID: mdl-24260891

RESUMO

In experimental animals with tumors it was studied antitumor activity of spirocyclic hydroxamic acids which could be classified as targeted agents as their target was enzyme histonedeacetylase, which was involved in the neoplastic process. The results showed that the hydroxamic acids were chemosensitizers for anticancer agents increasing their efficacy and enabling the researchers to reduce significantly the therapeutic dose. Also it was showed that hydroxamic acid, containing nitrogen mustard, was effective in the action on tumors with phenotype and genotype of multidrug resistance.


Assuntos
Antineoplásicos/farmacologia , Resistência a Múltiplos Medicamentos/efeitos dos fármacos , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Ácidos Hidroxâmicos/farmacologia , Neoplasias Experimentais/tratamento farmacológico , Animais , Antineoplásicos/uso terapêutico , Ciclofosfamida/administração & dosagem , Inibidores de Histona Desacetilases , Ácidos Hidroxâmicos/uso terapêutico , Leucemia P388/tratamento farmacológico , Metotrexato/administração & dosagem
2.
Vopr Onkol ; 57(3): 355-8, 2011.
Artigo em Russo | MEDLINE | ID: mdl-21882607

RESUMO

Treatment with low doses (1/10 of LD50) of cisplatin and platinum (IV)-nitroxyl complex VS118 [e-ammin-d-(4-amino-2,2,6,6-tetramethylpiperidine-1-oxyl)-a,f-bi s(acetate)-b,c-dichlorplatinum (IV)] was followed by a synergistic therapeutic effect (a 100% cure of animals) as compared with monotherapy with either drug. There was no synergistic increase in toxicity. The rates of resistance development decreased in the following order: P388/cPt+VS118, P388/cPt, P388/VS118. Resistant strains P388/cPt+VS18 and P388/VS118 were highly sensitive to doxorubicin, etoposide and cyclophoshamide. Further research in cPt+VS 118 combinations should be continued.


Assuntos
Antineoplásicos/farmacologia , Cisplatino/farmacologia , Resistencia a Medicamentos Antineoplásicos , Leucemia P388/tratamento farmacológico , Compostos Organoplatínicos/farmacologia , Compostos de Platina/farmacologia , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Cisplatino/administração & dosagem , Cisplatino/efeitos adversos , Ciclofosfamida/farmacologia , Doxorrubicina/farmacologia , Sinergismo Farmacológico , Etoposídeo/farmacologia , Camundongos , Óxidos de Nitrogênio/administração & dosagem , Óxidos de Nitrogênio/efeitos adversos , Óxidos de Nitrogênio/farmacologia , Compostos Organoplatínicos/administração & dosagem , Compostos de Platina/administração & dosagem , Compostos de Platina/efeitos adversos
3.
Vopr Onkol ; 43(3): 309-12, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9245088

RESUMO

Radiosensitizer AK-2123, a triazol, has been shown to significantly inhibit the development of hepatic metastases induced in syngeneic mice by intrasplenic injections with cels of bowel adenocarcinoma. The antimetastatic effect was produced by use of a very low dose of the drug. A therapeutic dose of AK-2123 has been shown to inhibit active transport of calcium ions across sarcoplasmic reticular cells effected by Ca(2+)-dependent Mg(2+)-activated ATPase. It is suggested that the antimetastatic effect of AK-2123 is determined by at least partial inhibition of active transport of calcium.


Assuntos
Adenocarcinoma/prevenção & controle , Bloqueadores dos Canais de Cálcio/farmacologia , Neoplasias Hepáticas Experimentais/prevenção & controle , Radiossensibilizantes/farmacologia , Triazóis/farmacologia , Adenocarcinoma/secundário , Animais , Antimetabólitos Antineoplásicos/farmacologia , Feminino , Fluoruracila/farmacologia , Neoplasias Hepáticas Experimentais/secundário , Camundongos , Camundongos Endogâmicos BALB C , Fatores de Tempo
4.
Eksp Onkol ; 10(6): 32-4, 1988.
Artigo em Russo | MEDLINE | ID: mdl-3243192

RESUMO

Peculiarities of growth and recurrences of the adenocarcinoma 755 are studied in C57Bl/6 mice and hybrids (DBA/2 X +C57Bl/6)F1 after chemotherapy with cyclophosphamide and 6-mercaptopurine (6-MP). The growth rate of tumours was practically identical in the both mice strains. Growth rate of recurrences was slower in examined lines than in corresponding tumours. The obtained results showed that the antitumour effect of the drugs, in particularly of 6-MP, and the growth rate of the first and that of the second recurrences clearly depended on the tumour host strain.


Assuntos
Adenocarcinoma/fisiopatologia , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Recidiva Local de Neoplasia/fisiopatologia , Adenocarcinoma/tratamento farmacológico , Animais , Ciclofosfamida/uso terapêutico , Avaliação Pré-Clínica de Medicamentos , Feminino , Mercaptopurina/uso terapêutico , Camundongos , Recidiva Local de Neoplasia/tratamento farmacológico , Transplante de Neoplasias , Fatores de Tempo
5.
Eksp Onkol ; 10(5): 49-52, 1988.
Artigo em Russo | MEDLINE | ID: mdl-3208690

RESUMO

The primary tumour properties are studied for their effect on the recurrent tumour growth and metastatic spreading after chemotherapy. Serial transplantation of the B16 melanoma to (CBA X C57Bl/6)F1 mice induced gradual changes in tumour malignancy. With an increase of the generation number the metastatic activity of hybrid mice rises and chemotherapeutic sensitivity lowers. The thirty-first and the fifty-fourth tumour generations after the chemotherapy metastasize earlier and the number of metastases increases more rapidly as compared with the recurrence of the primary tumour. The metastatic potential of recurrent tumours increases with the number of generations in hybrid mice.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Melanoma Experimental/patologia , Animais , Ciclofosfamida/administração & dosagem , Feminino , Melanoma Experimental/tratamento farmacológico , Metilnitrosoureia/administração & dosagem , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Metástase Neoplásica , Recidiva Local de Neoplasia , Transplante de Neoplasias
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...